Anti-Cancer Effect API Material 99% Taxol

China Anti-Cancer Effect API Material 99% Taxol, Find details about China Taxol, Anti-Cancer from Anti-Cancer Effect API Material 99% Taxol

Model NO.
Taxol
MW
853.906
Extraction Type
Solvent Extraction
Appearance
Almost White Powder
Storage
Cool Dried Storage
Shelf Life
24month
Trademark
HNB
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Origin
China
Model NO.
Taxol
MW
853.906
Extraction Type
Solvent Extraction
Appearance
Almost White Powder
Storage
Cool Dried Storage
Shelf Life
24month
Trademark
HNB
Transport Package
1kg/Bag, 25kg/Drum
Specification
99%
Origin
China
Anti-Cancer Effect API Material 99% Taxol
 
Product nameTaxolPayment Western Union, Alibaba Trade Assurance or TT
Appearancewhite powderDelivery By Couriers (DHL, FEDEX, EMS or TNT) or By Air
Specs99%Lead TimeWithin 3~5days 
CAS 33069-62-4PackageAluminum foil bag, Paperdrum or Cartons

Taxol/ Paclitaxel is a mitotic inhibitor used in cancer chemotherapy. It was discovered in a National Cancer Institute program at the Research Triangle Institute in 1967 when Monroe E. Wall and Mansukh C. Wani isolated it from the bark of the Pacific yew tree, Taxus brevifolia and named it 'taxol'. When it was developed commercially by Bristol-Myers Squibb (BMS) the generic name was changed to 'paclitaxel' and the BMS compound is sold under the trademark 'TAXOL'. In this formulation, paclitaxel is dissolved in Cremophor EL and ethanol, as a delivery agent. A newer formulation, in which paclitaxel is bound to albumin, is sold under the trademark Abraxane.

Function

Taxol/  Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi's sarcoma. Paclitaxel is also used for the prevention of restenosis. Paclitaxel stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division. Together with docetaxel, it forms the drug category of the taxanes .

Application

Taxol/Paclitaxel stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division. Together with docetaxel, it forms the drug category of the taxanes.

Anti-Cancer Effect API Material 99% Taxol


Anti-Cancer Effect API Material 99% Taxol

Tests

Standards

Results

Appearance

 white powder

Wcrystalline powder.hite,

Identification

A:IR absorption

Complies

Complies

B:UV absorption

Complies

Complies

C:TLC

Complies

Complies

Melting point

168~172°C

169.0~170.9°C

Water

Not more than0.5%

0.09%

Related substance

ImpurityJ(chloroacetanilide)not more than 10 ppm

2ppm

Impurity K(4-aminophenol)not more than 50 ppm

16 ppm

Impurity F(4-nitrophenol)not more than 0.05%

Not detected

any other impurity not more than 0.05%

0.01%

Total of other impurities not more than 0.1%

0.02%

Residue on ignition

Not more than 0.1%

0.05%

Chloride

Not more than 0.014%

Less than 0.014%

Sulfate

Not more than 0.02%

Less than 0.02%

Sulfide

Conforms

Conforms

Heavy metals

Not more than 0.001%

Less than 0.001%

Free p-aminophenol

Not more than 0.005%

Less than 0.005%

Limit of P-chloroacetanilide

Not more than 0.001%

Less than 0.001%

Readily carbonizable substances

Conforms

Conforms

Residual solvents

Residual content of acetic acid is limited by the test of loss on dryingnot more than0.5%

0.08%

Assay(anhydrous basis)

99.0~101.0%

99.4%

Conclusion:   Complies with USP34/ BP2011



Anti-Cancer Effect API Material 99% TaxolAnti-Cancer Effect API Material 99% TaxolAnti-Cancer Effect API Material 99% TaxolAnti-Cancer Effect API Material 99% TaxolAnti-Cancer Effect API Material 99% TaxolAnti-Cancer Effect API Material 99% TaxolAnti-Cancer Effect API Material 99% Taxol
Anti-Cancer Effect API Material 99% Taxol